Uralenol is a bioactive small molecule exhibiting dual inhibitory activity against PTP1B and mushroom tyrosinase (IC50 = 49.5 µM). It demonstrates potent anti-proliferative effects on ER-positive MCF-7 breast cancer cells in vitro, making it a candidate for research in metabolic disorders, oncology, and dermatology.
